Inhibition of sodium-glucose cotransporter 2 prevents sorafenib-induced depression-like behaviors by preserving hippocampal-dependent long-term potentiation
Pharmacology Biochemistry and Behavior · 2026
DOI: 10.1016/j.pbb.2026.174273 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacology Biochemistry and Behavior, 2026. Verfasst von Tien-Wei Hsu und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, College of Medicine, I-Shou University, Kaohsiung City, 82445, Taiwan; Department of Psychiatry, E-DA Dachang Hospital, I-Shou Un…. Hauptthemen laut MEDLINE: Long-Term Potentiation, Depression, Glucosides, Sorafenib. Die Arbeit nennt 68 Literaturangaben. Gefördert von: E-Da Hospital, National Science and Technology Council, UCSI University.
Themen: Depression
Abstract (Originalsprache)
The sodium-glucose cotransporter-2 (SGLT-2) inhibitor empagliflozin has been reported to exert significant neuroprotective effects on neurobehavioral deficits; however, its effects on chemotherapy-induced neuroplastic changes have not yet been investigated. The present study investigates the behavioral changes and hippocampal cellular responses through which empagliflozin exerts antidepressant effects against chemotherapy-induced pathological alterations. We employed a mouse model of depression-like behavior induced by oral administration of the chemotherapeutic agent sorafenib for 28 days. Sorafenib-induced cardiotoxicity was assessed using immunohistochemistry. Behavioral changes were evaluated using the forced swim test (FST), tail suspension test (TST), sucrose preference test (SPT), female urine sniffing test (FUST), and open field test (OFT). Synaptic transmission and long-term potentiation (LTP) at hippocampal Schaffer collateral-CA1 synapses were measured using extracellular field recordings. Oral administration of sorafenib induced macrophage infiltration and apoptosis in mouse hearts, whereas co-treatment with empagliflozin prevented these effects. In addition to cardiotoxicity, sorafenib also elicited depression-like behaviors, as evidenced by increased immobility time in the FST and TST, reduced sucrose preference in the SPT, decreased sniffing time in the FUST, and reduced time spent in the central zone during the OFT. Moreover, these neurological impairments were accompanied by a reduced input-output curve and diminished magnitude of LTP at hippocampal Schaffer collateral-CA1 synapses. Co-treatment with empagliflozin effectively prevented these neurological and cellular changes. Inhibition of sodium-glucose cotransporter-2 prevents sorafenib-induced depression-like behaviors and suppresses the decline in synaptic transmission and LTP in the hippocampus, thereby contributing to the antidepressant effects of empagliflozin.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, College of Medicine, I-Shou University, Kaohsiung City, 82445, Taiwan; Department of Psychiatry, E-DA Dachang Hospital, I-Shou University, Kaohsiung, Taiwan; Department of Psychiatry, E-DA Hospital,…
- Medical Laboratory, Medical Education and Research Center, Kaohsiung, Armed Forces General Hospital, Kaohsiung, Taiwan.
- Faculty of Pharmaceutical Sciences, UCSI University, Cheras, Kuala Lumpur, 56000, Malaysia; Centre of Research for Mental Health and Wellbeing, UCSI University, Cheras, Kuala Lumpur, 56000, Malaysia.
- School of Medicine, National Tsing Hua University, Hsinchu, 300044, Taiwan.
- School of Medicine, College of Medicine, I-Shou University, Kaohsiung City, 82445, Taiwan.
- Department of Pharmacy, College of Pharmacy, China Medical University, 100, Section 1, Jingmao Rd., Beitun Dist., Taichung City, 406040, Taiwan.
Förderung
- E-Da Hospital
- National Science and Technology Council
- UCSI University
- Government of Malaysia Ministry of Higher Education
Zitieren
APA
Hsu, T. W., Chu, T. H., Lee, M. T., Peng, W. H., Wu, C. C., Lee, Y. K., Teng, Y. N., & Ho, Y. C. (2026). Inhibition of sodium-glucose cotransporter 2 prevents sorafenib-induced depression-like behaviors by preserving hippocampal-dependent long-term potentiation. Pharmacology Biochemistry and Behavior. https://doi.org/10.1016/j.pbb.2026.174273
Vancouver
Hsu TW, Chu TH, Lee MT, Peng WH, Wu CC, Lee YK, et al. Inhibition of sodium-glucose cotransporter 2 prevents sorafenib-induced depression-like behaviors by preserving hippocampal-dependent long-term potentiation. Pharmacology Biochemistry and Behavior. 2026. doi:10.1016/j.pbb.2026.174273
BibTeX
@article{Hsu2026,
author = {Hsu, Tien-Wei and Chu, Tian-Huei and Lee, Ming Tatt and Peng, Wei-Hao and Wu, Cheng-Chun and Lee, Yung-Kuo and Teng, Yu-Ning and Ho, Yu-Cheng},
title = {Inhibition of sodium-glucose cotransporter 2 prevents sorafenib-induced depression-like behaviors by preserving hippocampal-dependent long-term potentiation},
journal = {Pharmacology Biochemistry and Behavior},
year = {2026},
doi = {10.1016/j.pbb.2026.174273}
}
EUVIMED